Accueil › Carcinome épidermoïde de la tête et du cou › Texas › San Antonio
Essais cliniques pour Carcinome épidermoïde de la tête et du cou à San Antonio, TX
22 études pour Carcinome épidermoïde de la tête et du cou recherchent des participants dans et autour de San Antonio (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Recrutement en coursPhase 1
- South Texas Accelerated Research Therapeutics (START), San Antonio
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Recrutement en coursPhase 1
- NEXT Oncology, San Antonio
Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
Recrutement en coursPhase 1
- NEXT Oncology - PARENT, San Antonio
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
Recrutement en coursPhase 1/2
- START South Texas Accelerated Research Therapeutics, San Antonio
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
Recrutement en coursPhase 1/2
- START Center for Cancer Research, San Antonio
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Recrutement en coursÉtude observationnelle
- The University of Texas Health Science Center at San Antonio, San Antonio
First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
Recrutement en coursPhase 1/2
- NEXT Oncology - San Antonio, San Antonio
A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC
Recrutement en coursPhase 1
- Site 102 - START San Antonio, San Antonio
ADCE-T02, a Tissue Factor Targeted Antibody-Drug Conjugate, in Patients With Selected Advanced Solid Tumours
Recrutement en coursPhase 1
- START San Antonio, San Antonio
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400
Recrutement en coursPhase 1
- START-San Antonio, San Antonio
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
Recrutement en coursPhase 1/2
- Research Site, San Antonio
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
Recrutement en coursPhase 1
- Normunity Investigational Site, San Antonio
Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors
Recrutement en coursPhase 1/2
- START San Antonio, San Antonio
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Recrutement en coursPhase 1
- NEXT Virginia, LLC, San Antonio
- South Texas Accelerated Research Therapeutics, LLC, San Antonio
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Recrutement en coursPhase 1/2
- START San Antonio, San Antonio
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Recrutement en coursPhase 1/2
- START, San Antonio
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
Recrutement en coursPhase 1
- NEXT Oncology /ID# 243007, San Antonio
- South Texas Accelerated Research Therapeutics (START) /ID# 276268, San Antonio
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
Recrutement en coursPhase 1
- NEXT Texas LLC - San Antonio, San Antonio
- START San Antonio, LLC, San Antonio
A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
Recrutement en coursPhase 3
- GSK Investigational Site, San Antonio
This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors
Recrutement en coursPhase 1
- NEXT Oncology, San Antonio
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Recrutement en coursPhase 1/2
- START San Antonio, San Antonio
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Recrutement en coursPhase 1
- Dren Investigational Site, San Antonio
Essais pour Carcinome épidermoïde de la tête et du cou dans d'autres villes
- Houston, TX47 études
- Los Angeles, CA42 études
- Boston, MA40 études
- New York City, NY39 études
- Nashville, TN39 études
- St. Louis, MO28 études
- Arlington, VA26 études
- Philadelphia, PA26 études
- Chicago, IL26 études
- Atlanta, GA24 études
- New Haven, CT22 études
- Pittsburgh, PA22 études
Autres études à San Antonio
- Cancer du poumon non à petites cellules59 études
- Cancer du sein47 études
- Cancer colorectal46 études
- Cancer métastatique44 études
- Cancer (tous types)41 études
- Obésité40 études
- Diabète de type 237 études
- Surpoids34 études
- Cancer de l'ovaire31 études
- Cancer du pancréas31 études
- Cancer de la prostate28 études
- Cancer de l'endomètre27 études
Source : ClinicalTrials.gov, données récupérées le 6 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.